Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges
- PMID: 38607025
- PMCID: PMC11011310
- DOI: 10.3390/cells13070586
Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges
Abstract
Achieving successful hematopoietic stem cell transplantation (HSCT) relies on two fundamental pillars: effective mobilization and efficient collection through apheresis to attain the optimal graft dose. These cornerstones pave the way for enhanced patient outcomes. The primary challenges encountered by the clinical unit and collection facility within a transplant program encompass augmenting mobilization efficiency to optimize the harvest of target cell populations, implementing robust monitoring and predictive strategies for mobilization, streamlining the apheresis procedure to minimize collection duration while ensuring adequate yield, prioritizing patient comfort by reducing the overall collection time, guaranteeing the quality and purity of stem cell products to optimize graft function and transplant success, and facilitating seamless coordination between diverse entities involved in the HSCT process. In this review, we aim to address key questions and provide insights into the critical aspects of mobilizing and collecting hematopoietic stem cells for transplantation purposes.
Keywords: CXCR4 antagonists; allogeneic; apheresis; autologous; mobilization; stem cell collection; transplant.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Factors for PBPC collection efficiency and collection predictors.Transfus Apher Sci. 2004 Dec;31(3):245-59. doi: 10.1016/j.transci.2004.09.008. Transfus Apher Sci. 2004. PMID: 15556472 Review.
-
Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center.J Clin Apher. 2020 Sep;35(5):453-459. doi: 10.1002/jca.21826. Epub 2020 Aug 15. J Clin Apher. 2020. PMID: 32798328
-
Mobilization of hematopoietic stem cells for use in autologous transplantation.Clin J Oncol Nurs. 2010 Apr;14(2):212-22. doi: 10.1188/10.CJON.212-222. Clin J Oncol Nurs. 2010. PMID: 20350895 Review.
-
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.Biol Blood Marrow Transplant. 2016 Apr;22(4):763-767. doi: 10.1016/j.bbmt.2015.11.016. Epub 2015 Nov 28. Biol Blood Marrow Transplant. 2016. PMID: 26643030
-
Optimized peripheral blood progenitor cell mobilization for autologous hematopoietic cell transplantation in children with high-risk and refractory malignancies.Pediatr Transplant. 2020 Feb;24(1):e13602. doi: 10.1111/petr.13602. Epub 2019 Oct 20. Pediatr Transplant. 2020. PMID: 31631445
Cited by
-
Hematopoietic stem cell transplantation in Crohn's disease: a comprehensive review.Curr Opin Gastroenterol. 2025 Jul 1;41(4):175-181. doi: 10.1097/MOG.0000000000001096. Epub 2025 Apr 14. Curr Opin Gastroenterol. 2025. PMID: 40232992 Free PMC article. Review.
-
Predicting apheresis yield and factors affecting peripheral blood stem cell harvesting using a machine learning model.J Int Med Res. 2024 Dec;52(12):3000605241305360. doi: 10.1177/03000605241305360. J Int Med Res. 2024. PMID: 39719078 Free PMC article.
-
Repurposing the prostaglandin analogue treprostinil and the calcium-sensing receptor modulator cinacalcet to revive cord blood as an alternate source of hematopoietic stem and progenitor cells for transplantation.Front Pharmacol. 2025 Jan 9;15:1444311. doi: 10.3389/fphar.2024.1444311. eCollection 2024. Front Pharmacol. 2025. PMID: 39850556 Free PMC article.
-
Population Pharmacokinetic-Pharmacodynamic Modeling of Granulocyte Colony-Stimulating Factor to Optimize Dosing and Timing for CD34+ Cell Harvesting.Clin Transl Sci. 2025 Jan;18(1):e70121. doi: 10.1111/cts.70121. Clin Transl Sci. 2025. PMID: 39748466 Free PMC article.
References
-
- Snowden J.A., Sánchez-Ortega I., Corbacioglu S., Basak G.W., Chabannon C., de la Camara R., Dolstra H., Duarte R.F., Glass B., Greco R., et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217–1239. doi: 10.1038/s41409-022-01691-w. - DOI - PMC - PubMed
-
- Carreras E., Dufour C., Mohty M., Kröger N. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Springer Nature; Cham, Switzerland: 2019. - PubMed
-
- Passweg J.R., Baldomero H., Chabannon C., Basak G.W., de la Cámara R., Corbacioglu S., Dolstra H., Duarte R., Glass B., Greco R., et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: Monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021;56:1651–1664. doi: 10.1038/s41409-021-01227-8. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources